SARS-CoV-2 Omicron Spike RBD Protein ABEI-Labeled

<strong>SARS-CoV-2 Omicron Spike RBD Protein ABEI-Labeled</strong>_x000D_ <strong>Catalog number:</strong> B2010593_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 30 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> SARS-CoV-2 B.1.1.529, Omicron RBD, Omicron Spike, Omicron RBD-ABEI_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <a href="https://moleculardepot.com/wp-content/uploads/2022/03/MKT-010-SARS-CoV-2-Brochure-Rev-A.pdf">Download SARS-CoV-2 Brochure</a>_x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Pruimboom L. SARS-CoV 2; Possible alternative virus receptors and_x000D_ pathophysiological determinants. Med Hypotheses. 2021 Jan;146:110368._x000D_ _x000D_ 2: Oroojalian F, Haghbin A, Baradaran B, Hemmat N, Shahbazi MA, Baghi HB,_x000D_ Mokhtarzadeh A, Hamblin MR. Novel insights into the treatment of SARS-CoV-2_x000D_ infection: An overview of current clinical trials. Int J Biol Macromol. 2020 Dec_x000D_ 15;165(Pt A):18-43._x000D_ _x000D_ 3: Bianchi M, Borsetti A, Ciccozzi M, Pascarella S. SARS-Cov-2 ORF3a: Mutability_x000D_ and function. Int J Biol Macromol. 2021 Feb 15;170:820-826._x000D_ _x000D_ 4: Dërmaku-Sopjani M, Sopjani M. Molecular Characterization of SARS-CoV-2. Curr_x000D_ Mol Med. 2021;21(7):589-595._x000D_ _x000D_ 5: Birgand G, Peiffer-Smadja N, Fournier S, Kerneis S, Lescure FX, Lucet JC._x000D_ Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings. JAMA Netw_x000D_ Open. 2020 Dec 1;3(12):e2033232._x000D_ _x000D_ 6: Mudgal R, Nehul S, Tomar S. Prospects for mucosal vaccine: shutting the door_x000D_ on SARS-CoV-2. Hum Vaccin Immunother. 2020 Dec 1;16(12):2921-2931._x000D_ _x000D_ 7: Vandelli A, Monti M, Milanetti E, Armaos A, Rupert J, Zacco E, Bechara E,_x000D_ Delli Ponti R, Tartaglia GG. Structural analysis of SARS-CoV-2 genome and_x000D_ predictions of the human interactome. Nucleic Acids Res. 2020 Nov_x000D_ 18;48(20):11270-11283._x000D_ _x000D_ 8: Pujadas E, Ibeh N, Hernandez MM, Waluszko A, Sidorenko T, Flores V, Shiffrin_x000D_ B, Chiu N, Young-Francois A, Nowak MD, Paniz-Mondolfi AE, Sordillo EM, Cordon-_x000D_ Cardo C, Houldsworth J, Gitman MR. Comparison of SARS-CoV-2 detection from_x000D_ nasopharyngeal swab samples by the Roche cobas 6800 SARS-CoV-2 test and a_x000D_ laboratory-developed real-time RT-PCR test. J Med Virol. 2020_x000D_ Sep;92(9):1695-1698._x000D_ _x000D_ 9: Jayamohan H, Lambert CJ, Sant HJ, Jafek A, Patel D, Feng H, Beeman M, Mahmood_x000D_ T, Nze U, Gale BK. SARS-CoV-2 pandemic: a review of molecular diagnostic tools_x000D_ including sample collection and commercial response with associated advantages_x000D_ and limitations. Anal Bioanal Chem. 2021 Jan;413(1):49-71._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/32562316/">_x000D_ 10: Cascarina SM, Ross ED. A proposed role for the SARS-CoV-2 nucleocapsid_x000D_ protein in the formation and regulation of biomolecular condensates. FASEB J._x000D_ 2020 Aug;34(8):9832-9842. </a>_x000D_ _x000D_ <strong>Products Related to SARS-CoV-2 Omicron Spike RBD Protein ABEI-Labelled</strong><a href="https://moleculardepot.com/product-category/Proteins/">: Proteins</a>